|1.||Rosewich, Martin: 2 articles (07/2013 - 02/2010)|
|2.||Zielen, Stefan: 2 articles (07/2013 - 02/2010)|
|3.||Richardson, Derek: 2 articles (07/2007 - 07/2004)|
|4.||Baldrick, Paul: 2 articles (07/2007 - 07/2004)|
|5.||Woroniecki, Stefan R: 2 articles (07/2007 - 07/2004)|
|6.||Aryan, Zahra: 1 article (12/2015)|
|7.||Rezaei, Nima: 1 article (12/2015)|
|8.||Lee, Denise: 1 article (07/2013)|
|9.||Fischer von Weikersthal-Drachenberg, Karl J: 1 article (02/2010)|
|10.||Schulze, Johannes: 1 article (02/2010)|
|1.||Seasonal Allergic Rhinitis (Hay Fever)
07/01/2013 - "A large clinical program has demonstrated efficacy and tolerability of Pollinex Quattro in children, adolescents and adults with grass and tree pollen allergy. "
10/01/2006 - "Pollinex Quattro is a novel, ultra short-course vaccine for treatment of seasonal allergic rhinitis from grass, tree or ragweed pollen allergy. "
11/01/2001 - "The standardisation of Pollinex Quattro tree pollen allergy vaccine is described and we include details of some innovative analytical procedures. "
07/01/2007 - "Pollinex Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL) for the treatment of ragweed pollen allergy."
12/01/2015 - "(Figure is included in full-text article.) To date, two allergy vaccine-containing TLR agonists have been investigated in clinical trials; Pollinex Quattro and AIC. "
03/01/2009 - "Pollinex Quattro Tree: allergy vaccine."
07/01/2007 - "A novel allergy vaccine (Pollinex Quattro Ragweed) has been developed for the prevention or relief of allergic symptoms caused by pollen from Ambrosia spp. (ragweed). "
10/01/2006 - "Pollinex Quattro: a novel and well-tolerated, ultra short-course allergy vaccine."
01/01/2006 - "Ultra-short-course seasonal allergy vaccine (Pollinex Quattro)."
|4.||Asthma (Bronchial Asthma)
|1.||monophosphoryl lipid A